Aurobindo Pharma stock hit a 52-week high at ₹1,585, and quoted close to its record high of ₹1,592 hit in September 2024.

Aurobindo subsidiary Eugia is back in hot water with the FDA after a recent plant inspection yielded yet another Form 483—this time in India. Following an inspection of an Eugia injectables facility ...

ETHealthworld.com brings latest aurobindo pharma news, views and updates from all top sources for the Indian Health industry.

An FDA inspection of an Aurobindo Pharma manufacturing facility last fall noted more than half a dozen concerns, but at the time the drugmaker indicated they should all be quickly fixable. Now that ...

Aurobindo Pharma USA, a subsidiary of Aurobindo Pharma, has entered into a definitive agreement to acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Aurobindo has received the Food and Drug Administration’s clearance for three generics. The company received approval for dutasteride & tamsulosin hydrochloride capsules 0.5 mg/0.4 mg, which is the ...

Hyderabad: Aurobindo Pharma’s US arm, Aurobindo Pharma USA, has received approval from the US Federal Trade Commission to acquire Lannett Company LLC in a $250 million transaction, clearing a key ...

Aurobindo Pharma Share Buyback, Aurobindo Pharma Buyback Price:Aurobindo Pharma on Monday (April 6) has announced a share buyback programme. Subject to required approvals from regulatory and/or ...